The immune landscape of myelodysplastic syndromes
Authors:
- 1 November 2016
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 107, 90-99
Abstract
No abstract availableKeywords
This publication has 131 references indexed in Scilit:
- Induction of myelodysplasia by myeloid-derived suppressor cellsJournal of Clinical Investigation, 2013
- Reversal of T-cell tolerance in myelodysplastic syndrome through lenalidomide immune modulationLeukemia, 2011
- Treating myelodysplastic syndrome improves an accompanying autoimmune disease along with a reduction in regulatory T-cellsLeukemia Research, 2011
- Abnormalities of the αβ T-cell receptor repertoire in advanced myelodysplastic syndromeExperimental Hematology, 2010
- Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseasesJournal of Autoimmunity, 2009
- Patients with myelodysplastic syndromes display several T-cell expansions, which are mostly polyclonal in the CD4+ subset and oligoclonal in the CD8+ subsetExperimental Hematology, 2009
- Altered naive and memory CD4+ T-cell homeostasis and immunosenescence characterize younger patients with myelodysplastic syndromeLeukemia, 2009
- Risks of myeloid malignancies in patients with autoimmune conditionsBritish Journal of Cancer, 2009
- Inhibition of overactivated p38 MAPK can restore hematopoiesis in myelodysplastic syndrome progenitorsBlood, 2006
- Molecular strategies for detection and quantitation of clonal cytotoxic T-cell responses in aplastic anemia and myelodysplastic syndromeBlood, 2006